We are live on
!
Find out more
PFM
Parsec Financial Management Portfolio holdings
AUM
$2.37B
1-Year Est. Return
4.66%
This Fund
S&P 500
This Quarter
Est. Return
+3.2%
1 Year Est. Return
-4.66%
3 Year Est. Return
+70.74%
5 Year Est. Return
+68.24%
10 Year Est. Return
+198.1%
AUM
$1.61B
AUM Growth
+$36.3M
(+2.3%)
Cap. Flow
-$6.66M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
25.83%
Holding
258
New
11
Increased
80
Reduced
117
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$7.36M |
| 2 |
UnitedHealth
UNH
|
+$4.39M |
| 3 |
Broadcom
AVGO
|
+$3.41M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$2.94M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$2.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$10.7M |
| 2 |
SAP
SAP
|
+$5.08M |
| 3 |
Zimmer Biomet
ZBH
|
+$4.43M |
| 4 |
HOLX
Hologic
HOLX
|
+$3.97M |
| 5 |
Microsoft
MSFT
|
+$3.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.22% |
| 2 | Financials | 13.49% |
| 3 | Healthcare | 11.32% |
| 4 | Consumer Staples | 7.98% |
| 5 | Industrials | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Monster Beverage
MNST
$95.1B
| $202K | 0.01% |
+6,320
| New | +$190K |
|
227
iShares Select Dividend ETF
DVY
$24B
| $201K | 0.01% |
+2,019
| New | +$199K |
|
228
Schwab US Broad Market ETF
SCHB
$42.7B
| $201K | 0.01% |
+17,136
| New | +$198K |
|
229
GE Aerospace
GE
$367B
| $180K | 0.01% |
3,437
-103
| -3% | -$5.07K |
|
230
FNB Corp
FNB
$6.78B
| $168K | 0.01% |
14,244
+1,072
| +8% | +$12.4K |
|
|
CBL
231
DELISTED
CBL& Associates Properties, Inc.
CBL
| $126K | 0.01% |
120,730
+15,000
| +14% | +$17.3K |
|
232
IAMGOLD
IAG
$8.07B
| $53K | ﹤0.01% |
15,600
| – | – |
|
233
Globalstar
GSAT
$10.2B
| $27K | ﹤0.01% |
3,740
| – | – |
|
234
Bristol-Myers Squibb
BMY
$130B
| – | – |
-4,197
| Closed | -$200K |
|
235
Check Point Software Technologies
CHKP
$14.3B
| – | – |
-13,140
| Closed | -$1.66M |
|
236
Clorox
CLX
$12B
| – | – |
-1,750
| Closed | -$281K |
|
237
Energizer
ENR
$1.47B
| – | – |
-4,819
| Closed | -$217K |
|
238
Ford
F
$61.8B
| – | – |
-16,120
| Closed | -$142K |
|
239
Fluor
FLR
$6.62B
| – | – |
-66,429
| Closed | -$2.44M |
|
240
Goldman Sachs
GS
$292B
| – | – |
-1,421
| Closed | -$273K |
|
241
Pitney Bowes
PBI
$2.42B
| – | – |
-25,000
| Closed | -$172K |
|
242
Vodafone
VOD
$37.3B
| – | – |
-10,033
| Closed | -$182K |
|
|
RTN
243
DELISTED
Raytheon Company
RTN
| – | – |
-1,160
| Closed | -$211K |
|
|
TNGN
244
DELISTED
TENGION INC COM NEW STK (DE)
TNGN
| $0 | ﹤0.01% |
50,000
| – | – |
|
Similar funds
EMG
AIA
HT
JCG
QA
BFG
IMOV
DW
Parsec Financial Management's Q2 2019 Portfolio in Review
As of Q2 2019, Parsec Financial Management held 258 positions worth $1.61B, up 2.3% from $1.57B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Parsec Financial Management's Q2 2019 filing shows 11 new, 80 increased, 117 reduced and 10 closed positions. Its largest new stake was Broadcom: 117,080 shares worth $3.37M. The largest sale was Abbott, an estimated $10.7M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Parsec Financial Management's largest Q2 2019 buy was Broadcom: 117,080 shares worth $3.37M.
- Parsec Financial Management added most to Gilead Sciences in Q2 2019, an estimated $7.36M increase.
- Parsec Financial Management's biggest Q2 2019 reduction was Abbott, cutting an estimated $10.7M.
- Parsec Financial Management fully exited Fluor in Q2 2019, selling an estimated $2.44M.
- Parsec Financial Management's ten largest holdings make up 26% of its $1.61B portfolio in Q2 2019.
- Parsec Financial Management opened 11 new positions and closed 10 in Q2 2019.
- Parsec Financial Management's portfolio value rose 2.3% quarter-over-quarter to $1.61B.
Based on Parsec Financial Management's 13F filing for Q2 2019, filed 23 Jul 2019.